Preview record
CJC-1295 No DAC 5 mg
Research reagent · 5 mg
A tetrasubstituted GRF(1-29) analogue without the DAC component (Modified GRF 1-29), lyophilised format, 5 mg per vial (declared).
The price is provisional. Ordering is not open yet — contact us and we will let you know when sales start.
Tell me when sales open01 / About the material
Description
This material corresponds to the short-acting GRF(1-29) analogue — the one the literature and the market call Modified GRF (1-29) or "CJC-1295 without DAC". It is regularly confused with CJC-1295 with DAC, a molecule carrying an albumin-binding linker and entirely different pharmacokinetics; they are different compounds.
The material is intended for laboratory research. Batch identity can be confirmed only after the relevant analytical documentation is reviewed.
Research context
The GRF(1-29) backbone is the shortest active GHRH fragment; four amino-acid substitutions increase the molecule's stability. The class's key clinical data belong to the DAC version (JCEM, 2006). The difference between the versions is covered in our comparison article.
- CJC-1295 with DAC vs without DAC: what is the difference?
- CJC-1295 and Ipamorelin: why does one name never travel without the other?
For laboratory and research purposes. Not intended for human use.
03 / FAQ
Frequent questions
- What is this material intended for?
- Strictly for laboratory research purposes. The material is not intended for human use and is not a medicine.
- Where is the batch documentation?
- Analytical documents appear on the page once their link to a specific batch is verified. Until then the documentation status honestly reads "pending review".
- When will ordering open?
- Ordering opens once catalogue verification, payment, and delivery are activated. Contact us and we will let you know when sales start.
04 / Catalogue
